Navigation Links
El Reino Unido, primer país europeo en ejecutar el programa Zostavax
Date:1/22/2013

LYON, Francia, January 22, 2013 /PRNewswire/ --

- El Reino Unido, primer país europeo en ejecutar el programa Zostavax para la vacunación contra el herpes zoster  

La vacuna se administrará a los mayores del Reino Unido para ayudar a proteger contra el herpes zoster

El Reino Unido ha decidido lanzar la primera campaña nacional de inmunización contra el herpes zoster (culebrilla) en Europa utilizando la innovadora vacuna Zostavax de Sanofi Pasteur MSD, la sociedad conjunta en Europa entre MSD y Sanofi Pasteur.

Los miembros mayores elegibles del público podrán recibir la vacuna Zostavax durante sus visitas médicas regulares o al mismo tiempo que la inyección para la gripe estacional. La decisión del Departamento de Salud del Reino Unido sigue una completa evaluación de los beneficios sanitarios y económicos de la vacuna del herpes zoster.

Zostavax es la primera y única vacuna disponible para la prevención del herpes zoster y el duradero dolor de origen nervioso que puede seguir a la enfermedad, conocida como neuralgia post-herpética. La vacuna está autorizada en Europa para la inmunización de adultos de más de 50 años* y puede darse como una sola inyección.

El herpes zoster es una enfermedad dolorosa y debilitadora que afecta a una de cada cuatro [1],[2] personas durante su vida. Cualquier persona que haya tenido la varicela (95 % de la población europea[3]) está potencialmente en riesgo ya que está causada por la reactivación del virus de la varicela que la mayor parte de la gente padece en la niñez.

El herpes zoster se caracteriza normalmente por un sarpullido extremadamente doloroso y ampollas en la piel, y puede producir complicaciones graves como neuralgia post-herpética, una condición dolorosa y duradera causada por el dañ
'/>"/>

SOURCE Sanofi Pasteur MSD
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. L.S.E. (Barcelona) anuncia la primera financiación del antiplaquetario NmC por inversores españoles y suizos
2. PrimeraDx Announces Commencement of Product Development Collaboration with Eli Lilly and Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... , Mar. 05, 2015 Research and ... the addition of the "Global Pharma US ... Cost Optimization Plays Major Role In Shaping Up ... to their offering. Strategy Diversification ... in healthy Cash position- Will accelerate Next wave ...
(Date:3/5/2015)... 2015  ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ... commercialization of targeted antiviral therapies, announced today that it ... Conference, to be held March 8-11, 2015, in ... James Sapirstein , Chief Executive Officer, will provide an ... and will be available to participate in one-on-one meetings ...
(Date:3/5/2015)... MENLO PARK, Calif. , March 5, 2015 /PRNewswire/ ... company in the emerging field of regenerative medicine, announced ... one of the nation,s top rehabilitation hospitals for spinal ... the Phase 1/2a clinical trial of AST-OPC1 (oligodendrocyte progenitor ... complete cervical spinal cord injury (SCI). ...
Breaking Medicine Technology:Global Pharma US & EU Outlook 2015: First -In-Class Innovations and Cost Optimization Plays Major Role In Shaping Up Business for Large Cap Pharmaceutical Companies 2Global Pharma US & EU Outlook 2015: First -In-Class Innovations and Cost Optimization Plays Major Role In Shaping Up Business for Large Cap Pharmaceutical Companies 3ContraVir to Present at 27th Annual ROTH Conference 2Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 4
... Thousand Oaks, Calif. and BRUSSELS, July 5, 2011 Amgen ... announced today that they are collaborating with the National Aeronautics ... preclinical test of a sclerostin antibody in an experiment that ... NASA shuttle mission, Space Shuttle Flight STS-135, scheduled to launch ...
... a Los Angeles-based neuromodulation company, today announced that ... external Trigeminal Nerve Stimulation (eTNS™) increased regional cerebral ... and mood regulation.  eTNS™ was shown to be ... in depression severity during the 8-week adjunctive treatment ...
Cached Medicine Technology:Amgen and UCB Team Up With NASA on Final Space Shuttle Mission to Conduct Preclinical Test of Sclerostin Antibody on Bone Loss 2Amgen and UCB Team Up With NASA on Final Space Shuttle Mission to Conduct Preclinical Test of Sclerostin Antibody on Bone Loss 3Amgen and UCB Team Up With NASA on Final Space Shuttle Mission to Conduct Preclinical Test of Sclerostin Antibody on Bone Loss 4Amgen and UCB Team Up With NASA on Final Space Shuttle Mission to Conduct Preclinical Test of Sclerostin Antibody on Bone Loss 5Amgen and UCB Team Up With NASA on Final Space Shuttle Mission to Conduct Preclinical Test of Sclerostin Antibody on Bone Loss 6Potential Mechanism of Action Identified for the Treatment of Major Depression With Trigeminal Nerve Stimulation (TNS) - The USB Port to the Brain™ 2Potential Mechanism of Action Identified for the Treatment of Major Depression With Trigeminal Nerve Stimulation (TNS) - The USB Port to the Brain™ 3Potential Mechanism of Action Identified for the Treatment of Major Depression With Trigeminal Nerve Stimulation (TNS) - The USB Port to the Brain™ 4
(Date:3/6/2015)... Virginia (PRWEB) March 06, 2015 The ... it has awarded five-year accreditation status to seven more ... mean that another 1.3 million people can now be ... protect and promote the health of their communities. , ... and improving the health of people and communities. Across ...
(Date:3/5/2015)... Shania Twain will be touring throughout North ... She has hinted that this will be her final tour and ... last time. She has had a residency in Las Vegas ... millions of loyal fans around the world. After opening in ... on June 30th she will be at Madison Square Garden (MSG) ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Risperdal ... in a Pennsylvania mass tort litigation currently underway ... a jury has begun hearing testimony in the ... atypical antipsychotic medication can cause gynecomastia, or male ... in question was filed on behalf of a ...
(Date:3/5/2015)... March 05, 2015 HomeCEUConnection.com ... March with extra savings on their nutrition ... of health and nutrition, HomeCEUConnection.com is offering ... the promo code, NUTRITION2015 . , ... , HomeCEUConnection.com provides high-quality continuing education ...
(Date:3/5/2015)... Battle Creek, Michigan (PRWEB) March 05, 2015 ... celebrates the opportunity to shatter myths about drug and ... Forever Recovery has released a Fact Sheet with information ... substance abuse. Launched in 2010 by the National Institute ... about drugs and alcohol aims to counteract the illusions ...
Breaking Medicine News(10 mins):Health News:Nearly 113 Million U.S. Residents Now Reaping Benefits of National Public Health Department Accreditation 2Health News:Nearly 113 Million U.S. Residents Now Reaping Benefits of National Public Health Department Accreditation 3Health News:Shania Twain Tickets: Ticket Down Announces Shania Twain's 2015 “Rock This Country” North American Tour 2Health News:Shania Twain Tickets: Ticket Down Announces Shania Twain's 2015 “Rock This Country” North American Tour 3Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 3Health News:HomeCEUConnection.com Offers Nutrition CEUs this March to Celebrate Nutrition Month 2Health News:A Forever Recovery Issues New Tips for Sobriety for National Drug Facts Week 2
... am ET, 9:00 am CT, LENEXA, Kan., Jan. ... will release its financial results for the,second quarter of ... host a teleconference call at 10:00 am Eastern Time ... There will be a question-and-answer,session directly following the presentation ...
... receive expansion ... ... million in grants to two nonprofit organizations through its,Highmark Healthy High ... and a self-esteem initiative, both available,throughout Highmark,s service area., "Increased ...
... for small doses of Plavix in children under 2 , , ... anti-clotting drug clopidogrel (Plavix) can benefit children under age 2 ... astonished at how little of the drug they needed to ... a fifth of the amount that we were expecting," Dr. ...
... Harbor Laboratory (CSHL) have reported new findings about how the ... help explain how we are able to focus on one ... or cocktail parties. , Neurons in the brains auditory ... rest of the nervous system, in the brain and spinal ...
... 15 Year Relationship with NBME and Announces ... Care Quality Certification Program, TAMPA, Fla., Jan. ... Utilization Review Physicians, Inc. (ABQAURP) is pleased to,announce ... National Board,of Medical Examiners(R) (NBME(SM)) to oversee and ...
... MACON, Ga., Jan. 29 Arcadian Health Plan, ... for Medicare,beneficiaries, has enhanced its benefits for 2008 ... comes on the heels of successful rollouts in,Oklahoma, ... the Georgia plans include $0 premiums, free annual,physicals ...
Cached Medicine News:Health News:Mediware to Report Second Quarter 2008 Financial Results on Tuesday, February 5th 2Health News:The Highmark Foundation Awards $4 Million in Highmark Healthy High 5 Grants to Two Nonprofit Organizations 2Health News:The Highmark Foundation Awards $4 Million in Highmark Healthy High 5 Grants to Two Nonprofit Organizations 3Health News:Anti-Clotting Drug Helps Infants With Heart Ills 2Health News:CSHL scientists make progress in determining how the brain selectively interprets sound 2Health News:ABQAURP Renews Agreement with the National Board of Medical Examiners to Oversee Testing Methodology 2Health News:ABQAURP Renews Agreement with the National Board of Medical Examiners to Oversee Testing Methodology 3Health News:New Options for Medicare Beneficiaries in Georgia 2
... Technologies, The UroMax Ultra ia designed ... high pressure and low profile., Refolding ... a remarkably strong material that is ... materials., Non-Compliant Balloons, A compliant balloon ...
... Fr Diameter with Two Large Working Channels; ... MICRO-6 Semi-Rigid Ureteroscope is the smallest ureteroscope ... and therapeutic procedures. The ACMI MICRO-6 Ureteroscope ... procedures with minimal or no dilation or ...
... is a self-dilating, semi-rigid autoclavable operating ureteroscope ... image bundle for an enhanced, clear image. ... to "0" diopters. The direction of view ... passage. The straight access operating channel is ...
... tip diameter of only 6.9Fr (2.3mm) ... range of 180 for and easy ... observation, a new optical system has ... (3.9mm) sheath dilator, 0.035" guidewire compatible, ...
Medicine Products: